Hepatitis C Treatment Initiation Among US Medicaid Enrollees

Australia News News

Hepatitis C Treatment Initiation Among US Medicaid Enrollees
Australia Latest News,Australia Headlines
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 42 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 20%
  • Publisher: 51%

Hep C treatment initiation low among Medicaid recipients cornell jamanetworkopen

We assigned each zip code to a decile of median family income, based on data from the American Community Survey.We conducted 2 preplanned sensitivity analyses. Because temporary disenrollment is common in Medicaid, we relaxed the enrollment criteria by requiring that individuals were enrolled for more than 1 day in each month .

We examined possible between-state vs within-state differences in 2 ways. First, we added to our regressions dichotomous indicators of a given patient’s residential state at the time of the index month . This approach controls for time-invariant linear trends within each state. We examined how estimated disparities changed after this adjustment.

Because we expected that between-state differences may be driven by Medicaid prior authorization policies in this time period, we specifically controlled for these policies as a second approach. If disparities were largely driven by these policies, we would expect to see attenuated associations between the other covariates and treatment uptake. Otherwise, the results would indicate that other unmeasured factors were driving the between-state differences.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

medical_xpress /  🏆 101. in UK

Australia Latest News, Australia Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Safeguarding mothers and newborns: the urgent need to address hepatitis during pregnancy - BMC MedicineSafeguarding mothers and newborns: the urgent need to address hepatitis during pregnancy - BMC Medicine
Read more »

Trimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage - Nature CommunicationsTrimannose-coupled antimiR-21 for macrophage-targeted inhalation treatment of acute inflammatory lung damage - Nature CommunicationsMacrophages are increasingly recognized as key drivers of lung damage in acute pneumonia including COVID-19. Here, the authors report on a first-in-class, inhalable, carbohydrate-coupled microRNA-inhibitor for selective targeting of macrophages and that prevents pulmonary hyperinflammation.
Read more »

New 'SPEEDY' treatment for stroke victims in the regionA study looking at improving stroke care in the West Midlands by taking patients directly to a specialist centre could help hundreds of people make a better recovery from stroke.
Read more »

The impact of epigenetic features on breast cancer treatment and outcomesThe impact of epigenetic features on breast cancer treatment and outcomesThe impact of epigenetic features on breast cancer treatment and outcomes Cancers_MDPI womenshealth epigenetics genetics epigenetic treatment cancer cancertreatment
Read more »

Nanotechnology's triple threat: Advancing precision cancer treatmentNanotechnology's triple threat: Advancing precision cancer treatmentNanotechnology's triple threat: Advancing precision cancer treatment Nature nanotechnology nanomedicine nano cancertreatment cancer therapy cancertherapy precisionmedicine personalisedmedicine
Read more »

More patients waiting over 52 weeks from referral to treatment in ShropshireMore patients waiting over 52 weeks from referral to treatment in ShropshireShropcom chief executive Patricia Davies highlighted the increase in waiting times due to the ‘level of demand’ on lower limb orthopaedic services.
Read more »



Render Time: 2025-03-01 22:46:18